ClinicalTrials.govpublic full text
SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations
sars-cov2 infection, sars-cov-2 acute respiratory disease, myeloma, leukemia, lymphoma, immune thrombocytopenia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 181593
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.